Perspectives on Regulatory T Cell Therapies. - Wikidata - awgldk - TriplyDB

Perspectives on Regulatory T Cell Therapies.

Perspectives on Regulatory T Cell Therapies.

http://www.wikidata.org/entity/Q34263542

about

FOXP3 and GARP (LRRC32): the master and its minion Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.How Soluble GARP Enhances TGFβ Activation.Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.Targeting regulatory T cells.FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR Demethylation.Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.

P2860

Q33673969-D606C0C8-4DE2-4AF4-B9C7-CCE663340095 Q34648541-607E3D0C-AAB9-4C11-8AFF-9E987853E917 Q35982318-4D089C85-243C-41E4-8A5D-A00958413225 Q36299565-74FD1FC9-CA41-460B-A0B6-AAEB760A7FA1 Q37983467-3EB4E925-BCEF-4506-9018-6CD970A1E294 Q42181657-B19B7D3F-E128-4D1E-8555-0035030B49DB Q51588372-9BFA39A9-5870-443D-8711-B5EE5891AF09

P2860

Perspectives on Regulatory T Cell Therapies.

http://www.wikidata.org/entity/Q34263542

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Perspectives on Regulatory T Cell Therapies.

@ast

Perspectives on Regulatory T Cell Therapies.

@en

Perspectives on Regulatory T Cell Therapies.

@nl

type

label

Perspectives on Regulatory T Cell Therapies.

@ast

Perspectives on Regulatory T Cell Therapies.

@en

Perspectives on Regulatory T Cell Therapies.

@nl

prefLabel

Perspectives on Regulatory T Cell Therapies.

@ast

Perspectives on Regulatory T Cell Therapies.

@en

Perspectives on Regulatory T Cell Therapies.

@nl

P1433

Q34263542-0CCC18E3-4D41-4C50-8DFC-7D28A81E6380

P1476

Q34263542-9A359DB1-6D57-4DE2-A152-6EE24B976FF6

P2093

Q34263542-239B7E19-EA3A-4C2B-B32D-7F3ABA863AE0

Q34263542-29AB4444-9F3D-4F7B-AE79-EF7644798C39

Q34263542-73CCFC8D-3876-4BF9-BCF5-3207D97572B8

Q34263542-EC7AF8B3-51A1-4091-BDC7-A866ACB1EDF9

P2860

Q34263542-029F2656-A3BF-4061-9DAA-3E1EF6C3D586

Q34263542-0609C52C-8FDE-40B0-AB7B-C8DC8C02AC76

Q34263542-0B7517A2-EA70-444B-B027-18F0A7AF5B6E

Q34263542-1CC97A0B-C4FC-41ED-AD7E-647FC84D4DDE

Q34263542-22513898-3B39-412D-BD50-936CA79E899C

Q34263542-259285E1-EC38-4FBF-9942-1231F34EE5A5

Q34263542-2A5DC96A-24AD-4E93-BC85-F3C667024C85

Q34263542-2BE0FC4B-68B4-4D1F-9E0F-6EE8F9895FD4

Q34263542-2DC007D0-B736-4AAF-9D33-18AE448B8AA7

Q34263542-3105EBD6-C6A3-4272-861A-3935CAD7C870

P304

Q34263542-6F77CB6A-4B0A-482D-A660-A10AE27DF886

P31

Q34263542-380272A6-F6F2-4C7A-8752-3F54B30D496C

P356

Q34263542-E8F0F72B-CF9B-404F-A56E-EF035FE24DAD

P433

Q34263542-4BF2C105-00C6-4048-88DA-20A070313EF9

P478

Q34263542-A08F9DB4-7C67-478E-8A60-B282E5352D68

P577

Q34263542-20C963D7-A6DF-492A-89A0-D628B9CEA5B3

P5875

Q34263542-CB410F35-AC02-4485-AF6E-44A455455BA8

P698

Q34263542-8623377F-445E-4DFE-A5BB-EBFC90A29E35

P932

Q34263542-AAA3FA7C-6459-4042-9A38-1EB33AE74DFA

P356

P1433

Transfusion Medicine and Hemotherapy

P1476

Perspectives on Regulatory T Cell Therapies.

@en

P2093

Andrea Kröger

http://www.w3.org/2001/XMLSchema#string

Henk S P Garritsen

http://www.w3.org/2001/XMLSchema#string

Jan Buer

http://www.w3.org/2001/XMLSchema#string

Michael Probst-Kepper

http://www.w3.org/2001/XMLSchema#string

P2860

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

Human T regulatory cell therapy: take a billion or so and call me in the morning

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins

Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

An essential role for Scurfin in CD4+CD25+ T regulatory cells

P304

302-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000235929

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47791951

http://www.w3.org/2001/XMLSchema#string

P698

21076548

http://www.w3.org/2001/XMLSchema#string

P932

2969127

http://www.w3.org/2001/XMLSchema#string